DNLI: Denali Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-04 | 13G amendment | BAILLIE GIFFORD & CO | 7.50% | SEC |
Institutional ownership (Q2 2026)
294 institutions reported holding $3.49B of Denali Therapeutics Inc. on Form 13F (269 the quarter before). 52 opened a new position and 28 sold out. Shares held by institutions: +6%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 14,026,413 | $360.76M |
| BAILLIE GIFFORD & CO | 11,960,230 | $307.62M |
| STATE STREET CORP | 7,049,304 | $181.31M |
| Temasek Holdings (Private) Ltd | 7,012,974 | $180.37M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,477,057 | $166.59M |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,275,729 | $161.41M |
| FMR LLC | 4,535,836 | $116.66M |
| GOLDMAN SACHS GROUP INC | 4,155,895 | $106.89M |
| GEODE CAPITAL MANAGEMENT, LLC | 3,973,342 | $102.21M |
| Holocene Advisors, LP | 3,905,225 | $100.44M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.